61.   The companies returned today without doing another study, though they said the new analyses and information about how the drug works should help support approval.

62.   The company did not return a call for comment.

63.   The company did not return a phone call Wednesday.

64.   The company did not return a telephone call Wednesday.

65.   The company did not return calls seeking comment on the incident.

66.   The company did not return calls to describe the circumstances.

67.   The company did not return phone calls for further comment.

68.   The company did not return phone calls Sunday.

69.   The company returned the data to Ehrenberg, a neurologist at New England Medical Center, for review.

70.   The company returned to operating profits only last year.